JENNIFER JOHNSON CROWDER: Open Payments
NPI 1437528304 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 66 payments from 11 companies in 2025. Trend: 2023 $814 · 2024 $693 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $165 |
| Novartis Pharmaceuticals Corporation | 11 | $159 |
| Merck Sharp & Dohme LLC | 8 | $159 |
| PFIZER INC. | 9 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Alnylam Pharmaceuticals Inc. | 4 | $73 |
| Medtronic, Inc. | 2 | $61 |
| Amgen Inc. | 3 | $45 |
| Philips North America LLC | 2 | $28 |
Products named: JARDIANCE, LEQVIO, VERQUVO, LifeVest, CAMZYOS, ELIQUIS, AMVUTTRA, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
